
Misook Yu
Supervisory Patent Examiner (ID: 2708, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 864 |
| Issued Applications | 263 |
| Pending Applications | 201 |
| Abandoned Applications | 403 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5237143
[patent_doc_number] => 20070129300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Cytotoxic factors for modulating cell death'
[patent_app_type] => utility
[patent_app_number] => 11/485252
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8710
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129300.pdf
[firstpage_image] =>[orig_patent_app_number] => 11485252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/485252 | Cytotoxic factors for modulating cell death | Jul 12, 2006 | Abandoned |
Array
(
[id] => 5183014
[patent_doc_number] => 20070054361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 11/486298
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 63707
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054361.pdf
[firstpage_image] =>[orig_patent_app_number] => 11486298
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/486298 | Compositions and methods for the diagnosis and treatment of tumor | Jul 12, 2006 | Abandoned |
Array
(
[id] => 4568077
[patent_doc_number] => 07858395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Antibodies for use in identifying and/or scoring prostate cancer and androgen receptor-dependent gene expression control'
[patent_app_type] => utility
[patent_app_number] => 11/995387
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 14036
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995387
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995387 | Antibodies for use in identifying and/or scoring prostate cancer and androgen receptor-dependent gene expression control | Jul 12, 2006 | Issued |
Array
(
[id] => 5851099
[patent_doc_number] => 20060234290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Novel genes and expression products therefrom'
[patent_app_type] => utility
[patent_app_number] => 11/476634
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12243
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234290.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476634 | Novel genes and expression products therefrom | Jun 28, 2006 | Abandoned |
Array
(
[id] => 5159858
[patent_doc_number] => 20070172902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Biomarker for ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 11/473280
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16167
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172902.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473280
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473280 | Biomarker for ovarian cancer | Jun 20, 2006 | Abandoned |
Array
(
[id] => 5661558
[patent_doc_number] => 20060252154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Assay to identify estrogen receptor dependent ligands that regulate the hepatic lipase promoter'
[patent_app_type] => utility
[patent_app_number] => 11/471781
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8299
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252154.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471781
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471781 | Assay to identify estrogen receptor dependent ligands that regulate the hepatic lipase promoter | Jun 20, 2006 | Issued |
Array
(
[id] => 5231467
[patent_doc_number] => 20070293575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Compounds and methods for treatment of cancer-related anemia'
[patent_app_type] => utility
[patent_app_number] => 11/455202
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33797
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11455202
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/455202 | Compounds and methods for treatment of cancer-related anemia | Jun 14, 2006 | Abandoned |
Array
(
[id] => 5480633
[patent_doc_number] => 20090203590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'METHOD FOR THE INHIBITION OF ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 11/915417
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15539
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203590.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915417
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915417 | METHOD FOR THE INHIBITION OF ANGIOGENESIS | May 29, 2006 | Abandoned |
Array
(
[id] => 4872735
[patent_doc_number] => 20080199469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Regulation and function of TPL-2'
[patent_app_type] => utility
[patent_app_number] => 11/441507
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24152
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199469.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441507
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441507 | Regulation and function of TPL-2 | May 25, 2006 | Abandoned |
Array
(
[id] => 7597644
[patent_doc_number] => 07618933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-17
[patent_title] => 'Treatment of follicular lymphomas using inhibitors of the LT pathway'
[patent_app_type] => utility
[patent_app_number] => 11/411049
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8036
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/618/07618933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411049
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411049 | Treatment of follicular lymphomas using inhibitors of the LT pathway | Apr 24, 2006 | Issued |
Array
(
[id] => 5678331
[patent_doc_number] => 20060183687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Novel therapeutic molecules'
[patent_app_type] => utility
[patent_app_number] => 11/409944
[patent_app_country] => US
[patent_app_date] => 2006-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 25933
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11409944
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/409944 | Therapeutic molecules | Apr 23, 2006 | Issued |
Array
(
[id] => 5367115
[patent_doc_number] => 20090304674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'METHODS FOR TREATING DISEASE BY REGULATING CLL CELL SURVIVAL'
[patent_app_type] => utility
[patent_app_number] => 11/919013
[patent_app_country] => US
[patent_app_date] => 2006-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14055
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304674.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919013 | METHODS FOR TREATING DISEASE BY REGULATING CLL CELL SURVIVAL | Apr 23, 2006 | Abandoned |
Array
(
[id] => 4994088
[patent_doc_number] => 20070009433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => '14094, a novel human trypsin family member and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/403988
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 49127
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403988
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403988 | 14094, a novel human trypsin family member and uses thereof | Apr 12, 2006 | Abandoned |
Array
(
[id] => 5106563
[patent_doc_number] => 20070065440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Antibody compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/401745
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 38429
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065440.pdf
[firstpage_image] =>[orig_patent_app_number] => 11401745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/401745 | Antibody compositions and methods | Apr 9, 2006 | Abandoned |
Array
(
[id] => 5508503
[patent_doc_number] => 20090081710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Method for Cancer Prognosis Using Cellular Folate Vitamin Receptor Quantification'
[patent_app_type] => utility
[patent_app_number] => 11/887438
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12427
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081710.pdf
[firstpage_image] =>[orig_patent_app_number] => 11887438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/887438 | Method for Cancer Prognosis Using Cellular Folate Vitamin Receptor Quantification | Mar 29, 2006 | Abandoned |
Array
(
[id] => 5760113
[patent_doc_number] => 20060211058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Diagnosis and treatment of malignant neoplasms'
[patent_app_type] => utility
[patent_app_number] => 11/376941
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14740
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211058.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376941
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376941 | Diagnosis and treatment of malignant neoplasms | Mar 14, 2006 | Abandoned |
Array
(
[id] => 5682963
[patent_doc_number] => 20060199233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'miR-155 assay'
[patent_app_type] => utility
[patent_app_number] => 11/352837
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9400
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199233.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352837
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352837 | miR-155 assay | Feb 12, 2006 | Issued |
Array
(
[id] => 4739490
[patent_doc_number] => 20080233143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Adjuvanting Material'
[patent_app_type] => utility
[patent_app_number] => 11/815857
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4890
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233143.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815857
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815857 | Adjuvanting Material | Feb 6, 2006 | Abandoned |
Array
(
[id] => 281933
[patent_doc_number] => 07553933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Human p51 genes and gene products thereof'
[patent_app_type] => utility
[patent_app_number] => 11/340715
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26357
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11340715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/340715 | Human p51 genes and gene products thereof | Jan 26, 2006 | Issued |
Array
(
[id] => 4812815
[patent_doc_number] => 20080193446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Compositions and Methods for the Diagnosis and Treatment of Tumor'
[patent_app_type] => utility
[patent_app_number] => 11/814954
[patent_app_country] => US
[patent_app_date] => 2006-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 55508
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814954
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814954 | Compositions and Methods for the Diagnosis and Treatment of Tumor | Jan 24, 2006 | Abandoned |